Optimization of targeted therapies to inhibit smooth muscle cell invasion in vitro

被引：0

作者：

Kennedy, CE ^{[1
]}

Massia, SP ^{[1
]}

机构：

[1] Arizona State Univ, Harrington Dept Bioengn, Lab Cellular & Biomat Interact, Tempe, AZ 85287 USA

来源：

PROCEEDINGS OF THE 25TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOLS 1-4: A NEW BEGINNING FOR HUMAN HEALTH | 2003年 / 25卷

关键词：

hyperplasia; smooth muscle cells; invasion; migration; integrin; peptide;

D O I：

10.1109/IEMBS.2003.1279470

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Vascular smooth muscle cell (VSMC) proliferation and migration has been correlated with intimal hyperplasia (111) after vascular interventions such as angioplasty, stenting, and vascular graft surgery. Therefore, therapies targeting inhibition of VSMC migration may lead to higher patency rates in vascular grafts and reduced III in other vascular interventions. This study tested three targeted therapies and their combinations: hyperfunctional alpha(v)beta(3) integrin expression, cyclic-RGD release and tissue inhibitor of metalloprotease (TIMP)-1 release. It was found that a combination of 1.0 mM cyclic-RGD and 10 ng/mL TIMP-1 maximally inhibited smooth muscle cell invasion over individual or other combinations of treatments over 72 hours.

引用

页码：1215 / 1218

页数：4

共 50 条

[1] Green tea catechins inhibit the cultured smooth muscle cell invasion through the basement barrier
Maeda, K
Kuzuya, M
Cheng, XW
Asai, T
Kanda, S
Tamaya-Mori, N
Sasaki, T
Shibata, T
Iguchi, A
ATHEROSCLEROSIS, 2003, 166 (01) : 23 - 30
[2] SKELETAL MUSCLE RELAXANTS INHIBIT RAT TRACHEAL SMOOTH MUSCLE TONE IN VITRO
Milchert, M.
Spassov, A.
Meissner, K.
Nedeljkov, V.
Lehmann, C.
Wendt, M.
Loster, B. W.
Mazurkiewicz-Janik, M.
Gedrange, T.
Pavlovic, D.
JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2009, 60 : 5 - 11
[3] Interferons significantly inhibit smooth muscle cell growth in the absence of significant endothelial toxicity in vitro
Kipshidze, N
Chekanov, V
Moussa, I
Tsapenko, M
Nikolaychik, V
Khanna, A
AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (6A): : 226L - 227L
[4] Thiazolidinediones inhibit airway smooth muscle release of the chemokine CXCL10: in vitro comparison with current asthma therapies
Seidel, Petra
Alkhouri, Hatem
Lalor, Daniel J.
Burgess, Janette K.
Armour, Carol L.
Hughes, J. Margaret
RESPIRATORY RESEARCH, 2012, 13
[5] Thiazolidinediones inhibit airway smooth muscle release of the chemokine CXCL10: in vitro comparison with current asthma therapies
Petra Seidel
Hatem Alkhouri
Daniel J Lalor
Janette K Burgess
Carol L Armour
J Margaret Hughes
Respiratory Research, 13
[6] On the ability of imatinib mesylate to inhibit smooth muscle cell proliferation without delaying endothelialization: An in vitro study
Vallieres, Karine
Petitclerc, Eric
Laroche, Gaetan
VASCULAR PHARMACOLOGY, 2009, 51 (01) : 50 - 56
[7] eNOS gene transfected endothelial cells inhibit smooth muscle cell proliferation and platelet aggregation in vitro
Xue, GH
Zhang, JW
Zhang, H
Zhang, BG
Sun, ML
MOLECULAR THERAPY, 2004, 9 : S150 - S150
[8] A Mixture of Fibronectin, Fibrinogen and Tropoelastin is Able to Inhibit Smooth Muscle Cell Migration and to Promote Reendothelialization in vitro
Tersteeg, Claudia
Roest, Mark
Mak-Nienhuis, Elske M.
Ligtenberg, Erik
Hoefer, Imo
de Groot, Philip G.
Pasterkamp, Gerard
CIRCULATION, 2011, 124 (21)
[9] eNOS-overexpressing endothelial cells inhibit platelet aggregation and smooth muscle cell proliferation in vitro
Kader, KN
Akella, R
Ziats, NP
Lakey, LA
Harasaki, H
Ranieri, JP
Bellamkonda, RV
TISSUE ENGINEERING, 2000, 6 (03): : 241 - 251
[10] PKA and Epac synergistically inhibit smooth muscle cell proliferation
Hewer, Richard C.
Sala-Newby, Graciela B.
Wu, Yih-Jer
Newby, Andrew C.
Bond, Mark
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2011, 50 (01) : 87 - 98

← 1 2 3 4 5 →